Revian, Inc.

Founded in 2016 and headquartered in Durham, US, Revian, Inc. specializes in hair growth solutions. In November 2025, Revian, Inc. raised USD 3.

59 million series A funding led by Flashpoint. The round was part of a larger USD 13 million in equity and debt funding. The series A funding values Revian, Inc. at USD 20.

55 million post-money. Revian, Inc. specializes in advanced hair growth solutions, primarily through its flagship product, the REVIAN Red Hair Growth System. This system employs patented dual-wavelength laser light therapy (LLLT) technology to stimulate hair follicles and promote hair regrowth without chemicals or pills.

It includes a wireless cap paired with a smart mobile application for tracking treatment compliance. The REVIAN Red device is clinically validated for halting hair loss and enhancing volume, particularly for androgenetic alopecia in men and women, with over 2,000 medical providers recommending the treatment in the US. Revian generates revenue primarily through direct-to-consumer sales of its REVIAN Red and REVIAN Lyte devices, marketed as all-natural hair loss solutions. Purchases include a money-back guarantee to promote compliance with treatment protocols.

Revenue streams also include potential subscription models via the supporting smart app and partnerships with healthcare professionals recommending the devices as part of broader treatment plans. The company offers promotional discounts during events like Black Friday to boost consumer engagement. The organization plans to use the November 2025 funding to enhance its commercial activities, broaden its product offerings, and facilitate expansion into global markets.